ArticleJAAD case reports2023
A case of generalized granuloma annulare treated with upadacitinib.
Article in JAAD case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.
- Management Strategies for Generalised Granuloma Annulare: A Systematic Review of Current and Emerging Therapies.The Australasian journal of dermatology · 2025Pooled it
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology.Medicina (Kaunas, Lithuania) · 2026Review
- Treatment of Generalized Granuloma Annulare with JAK Inhibitors: Systematic Review.Clinical, cosmetic and investigational dermatology · 2026Review
- Jak1 Inhibition Is Sufficient for Treatment of Granuloma Annulare.The Journal of investigative dermatology · 2025Article
- [Clinical variables and management of disseminated granuloma annulare - monocentric retrospective analysis of 33 cases between 2021 and 2023].Dermatologie (Heidelberg, Germany) · 2025Article
- A Case of Severe Generalized Granuloma Annulare Responding Well to Tofacitinib.Case reports in dermatological medicine · 2025Article
- Recalcitrant cutaneous sarcoidosis treated with upadacitinib: Case report.JAAD case reports · 2024Article
- Disseminated granuloma annulare: a cutaneous sign of diabetes mellitus.BMJ case reports · 2024Article
- Successful Treatment of Disseminated Granuloma Annulare with Upadacitinib.Dermatology and therapy · 2024Article
- Successful Treatment of Refractory Generalized Granuloma Annulare with Upadacitinib.Case reports in dermatological medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.